AzTrials
AzTrials

Medical MalpracticeNCT07869303

The Impact of AI-Assisted Diagnosis and Treatment on Physicians' Potential Legal Liability: An Expert Perspective

A study testing General AI With a Standard-of-Care Recommendation, General AI With a Non-Standard-of-Care Recommendation and Expert AI With a Standard-of-Care Recommendation in people with Medical Malpractice and Artificial Intelligence in Medicine, run by Xie Xiaoyun.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this randomized vignette-based experiment is to investigate how AI-related contextual factors influence expert assessment of physician negligence in AI-assisted diagnosis and treatment scenarios among experts in medical malpractice assessment. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
General AI With a Standard-of-Care Recommendation, General AI With a Non-Standard-of-Care Recommendation and Expert AI With a Standard-of-Care Recommendation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
440 participants
Where
No sites listed yet
Study dates
30 Sep 2026to 20 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Physicians qualified to participate in medical negligence assessments, generally holding the title of associate chief physician or above and having relevant clinical experience; or forensic medical experts affiliated with an officially recognized forensic assessment institution and qualified to conduct medical negligence assessments independently.
  • Able to read and understand the clinical vignettes and complete the online survey independently.

Who cannot join

  • Physicians who are not qualified to participate in medical negligence assessments.
  • Forensic medical experts who are not qualified to conduct medical negligence assessments independently or are not affiliated with an officially recognized forensic assessment institution.
  • Unable to understand or complete the vignette-based online survey.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Xiaoyun Xie, Master contact

+86 18061291721

xxy996269@163.com

About this study

The goal of this randomized vignette-based experiment is to investigate how AI-related contextual factors influence expert assessment of physician negligence in AI-assisted diagnosis and treatment scenarios among experts in medical malpractice assessment.

The main questions it aims to answer are:

Read more

Does physician acceptance or rejection of AI recommendations, compared with non-AI use, influence the likelihood of being assessed as negligent?

Researchers will compare a no-AI assistance control group with four AI-assistance groups under different AI use conditions to examine how AI involvement and contextual factors affect assessments of physician negligence.

Participants will:

Complete a web-based questionnaire after eligibility confirmation. Evaluate a series of clinical vignettes describing adverse patient outcomes following physician decision-making under different AI-use conditions.

Read the detailed description

Using a randomized vignette-based experiment, this study will empirically examine how contextual factors identified through a literature review and expert consultation influence assessments of physician negligence. The vignettes will vary factors such as the physician's clinical competence and use of AI and will be presented in randomized order to physicians potentially qualified to participate in medicolegal assessments. Participants will then determine whether the physician's final clinical decision in each vignette constitutes negligence. Participants will be randomly assigned using simple randomization to one no-AI control group or one of four AI intervention groups. Based on the contextual factors identified, the study will include as many factors as feasible within the available sample size, with clearly defined factors examined in the primary or exploratory analyses. Different vignettes will be constructed using combinations of these factors. After assessing whether the physician in each vignette was negligent, participants will also complete measures concerning the extent to which the physician fulfilled the duty of care, their confidence in the assessment, and the allocation of responsibility among the AI developer, healthcare institution, physician, and others (e.g., disease/patient-related factors). These data will be used to identify the circumstances under which accepting or rejecting an AI recommendation is more likely to be considered negligent and to examine medicolegal experts' current attitudes toward the role of medical AI in assessments of medical malpractice.

Being tested
General AI With a Standard-of-Care Recommendation, General AI With a Non-Standard-of-Care Recommendation, Expert AI With a Standard-of-Care Recommendation, Expert AI With a Non-Standard-of-Care Recommendation
Keywords
Artificial intelligence, clinical decision support, medical negligence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • General AI With a Standard-of-Care RecommendationOther

    Participants will evaluate four clinical vignettes involving a general AI system whose historical performance is comparable to that of a township hospital attending physician. The AI provides a recommendation consistent with the standard of care. Physician capability and acceptance or rejection of the AI recommendation vary across the vignettes.

  • General AI With a Non-Standard-of-Care RecommendationOther

    Participants will evaluate four clinical vignettes involving a general AI system whose historical performance is comparable to that of a township hospital attending physician. The AI provides a recommendation inconsistent with the standard of care. Physician capability and acceptance or rejection of the AI recommendation vary across the vignettes.

  • Expert AI With a Standard-of-Care RecommendationOther

    Participants will evaluate four clinical vignettes involving an expert AI system whose historical performance is comparable to that of a tertiary hospital chief physician. The AI provides a recommendation consistent with the standard of care. Physician capability and acceptance or rejection of the AI recommendation vary across the vignettes.

  • Expert AI With a Non-Standard-of-Care RecommendationOther

    Participants will evaluate four clinical vignettes involving an expert AI system whose historical performance is comparable to that of a tertiary hospital chief physician. The AI provides a recommendation inconsistent with the standard of care. Physician capability and acceptance or rejection of the AI recommendation vary across the vignettes.

Study groups in NCT07869303
Study groupRoleWhat they receive
No AI Assistance (Control Group)No interventionNo AI Assistance (Control Group)
Intervention Group 1Active comparatorGeneral AI with a Standard-of-Care Recommendation
Receives: Other: General AI With a Standard-of-Care Recommendation
Intervention Group 2Active comparatorGeneral AI with a Non-Standard-of-Care Recommendation
Receives: Other: General AI With a Non-Standard-of-Care Recommendation
Intervention Group 3Active comparatorExpert AI with a Standard-of-Care Recommendation
Receives: Other: Expert AI With a Standard-of-Care Recommendation
Intervention Group 4Active comparatorExpert AI with a Non-Standard-of-Care Recommendation
Receives: Other: Expert AI With a Non-Standard-of-Care Recommendation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Physician Negligence Assessment

    Participants will assess whether the physician fulfilled the duty of care in each clinical vignette. Responses are recorded as "Yes" (no negligence) or "No" (negligence).

    Measured: Immediately after each clinical vignette during the single online survey session.

Secondary outcomes (6)
  1. Reasonableness of the Physician's Decision

    Participants will rate the extent to which a reasonable physician would make the same decision under similar circumstances. Scores range from 1 (definitely would not) to 7 (definitely would), with higher scores indicating greater perceived reasonableness.

    Measured: Immediately after each clinical vignette during the single online survey session.

  2. Magnitude of Physician Fault

    Participants will rate the magnitude of the physician's fault using a visual analogue scale ranging from 0 (completely faultless) to 100 (completely at fault). Higher scores indicate greater perceived fault.

    Measured: Immediately after each clinical vignette during the single online survey session.

  3. Allocation of Responsibility

    Participants will allocate responsibility for the adverse outcome among the physician, healthcare institution, AI developer and others(e.g. patient, disease factors). The percentages assigned to the three parties must total 100%.

    Measured: Immediately after each clinical vignette during the single online survey session.

  4. Confidence in the Assessment

    Participants will rate their confidence in their assessments on a 7-point Likert scale ranging from 1 (very unconfident) to 7 (very confident). Higher scores indicate greater confidence.

    Measured: Immediately after each clinical vignette during the single online survey session.

  5. Intention to Use AI in Future Clinical Practice

    Participants will rate their intention to use AI to support future clinical decision-making on a 7-point Likert scale ranging from 1 (very unwilling) to 7 (very willing). Higher scores indicate greater intention to use AI.

    Measured: Immediately after completion of all four clinical vignettes during the single online survey session.

  6. Confidence in Using AI in Future Clinical Practice

    Participants will rate their confidence in using AI to support future clinical decision-making on a 7-point Likert scale ranging from 1 (not confident at all) to 7 (completely confident). Higher scores indicate greater confidence in using AI.

    Measured: Immediately after completion of all four clinical vignettes during the single online survey session.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2026
  2. Study start30 Sep 2026 (estimated)
  3. Primary completion15 Jun 2027 (estimated)
  4. Study completion20 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
440 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07869303
Sponsor's protocol ID
[2026] Thesis Review No.(S102)
Status last verified
Sep 2026
First submitted
16 Sep 2026
Last updated
9 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: According to the research protocol, individual participant data from this study cannot be deposited in a public data repository but can be made available for research purposes upon request. Researchers can request the de-identified data by submitting a data use agreement (DUA) to the Medical Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology. The DUA must state that the data will be used for research purposes only and that no attempt will be made to re-identify participants. Upon approval of the request, the data will be made available. The contact information is as follows: tongjilunli@vip.163.com (email); +86-27-83691785 (fax); Office 12, 16th Floor, Teaching Building 2, School of Basic Medicine, Tongji Medical College, No. 13 Hangkong Road, Wuhan, Hubei Province, China (address).

Questions about this trial

What is this clinical trial studying?

A study testing General AI With a Standard-of-Care Recommendation, General AI With a Non-Standard-of-Care Recommendation and Expert AI With a Standard-of-Care Recommendation in people with Medical Malpractice and Artificial Intelligence in Medicine, run by Xie Xiaoyun.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Xiaoyun Xie, Master (+86 18061291721, xxy996269@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Physician Negligence Assessment (time frame: Immediately after each clinical vignette during the single online survey session.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in